Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its… bypharmanewsdailySeptember 25, 2020
